Affiliations: [a] Laboratory of Signal Image and Energy Mastery, National Higher Engineering School of Tunis, University of Tunis, Tunis, Tunisia
| [b] Laboratory of Biophysics and Medical Technologies, Higher Institute of Medical Technologies of Tunis, University of Tunis El Manar, Tunis, Tunisia
Correspondence:
[*]
Corresponding author: Amine Ben Slama, Laboratory of Biophysics and Medical Technologies, Higher Institute of Medical Technologies of Tunis (ISTMT), University of Tunis El Manar, 9, Avenue Dr Zouhair Essafi – 1006 Tunis. Tel.: +216 97 968 181; E-mail: amine.benslama@istmt.utm.tn.
Abstract: Computerized segmentation of brain tumor based on magnetic resonance imaging (MRI) data presents an important challenging act in computer vision. In image segmentation, numerous studies have explored the feasibility and advantages of employing deep neural network methods to automatically detect and segment brain tumors depicting on MRI. For training the deeper neural network, the procedure usually requires extensive computational power and it is also very time-consuming due to the complexity and the gradient diffusion difficulty. In order to address and help solve this challenge, we in this study present an automatic approach for Glioblastoma brain tumor segmentation based on deep Residual Learning Network (ResNet) to get over the gradient problem of deep Convolutional Neural Networks (CNNs). Using the extra layers added to a deep neural network, ResNet algorithm can effectively improve the accuracy and the performance, which is useful in solving complex problems with a much rapid training process. An additional method is then proposed to fully automatically classify different brain tumor categories (necrosis, edema, and enhancing regions). Results confirm that the proposed fusion method (ResNet-SVM) has an increased classification results of accuracy (AC = 89.36%), specificity (SP = 92.52%) and precision (PR = 90.12%) using 260 MRI data for the training and 112 data used for testing and validation of Glioblastoma tumor cases. Compared to the state-of-the art methods, the proposed scheme provides a higher performance by identifying Glioblastoma tumor type.
